224 related articles for article (PubMed ID: 33677570)
1. The Mitragyna speciosa (Kratom) Genome: a resource for data-mining potent pharmaceuticals that impact human health.
Brose J; Lau KH; Dang TTT; Hamilton JP; Martins LDV; Hamberger B; Hamberger B; Jiang J; O'Connor SE; Buell CR
G3 (Bethesda); 2021 Apr; 11(4):. PubMed ID: 33677570
[TBL] [Abstract][Full Text] [Related]
2. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
[TBL] [Abstract][Full Text] [Related]
3. Metabolite and Molecular Characterization of
Laforest LC; Kuntz MA; Kanumuri SRR; Mukhopadhyay S; Sharma A; O'Connor SE; McCurdy CR; Nadakuduti SS
J Nat Prod; 2023 Apr; 86(4):1042-1052. PubMed ID: 36913648
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of kratom opioids.
Kim K; Shahsavarani M; Garza-García JJO; Carlisle JE; Guo J; De Luca V; Qu Y
New Phytol; 2023 Oct; 240(2):757-769. PubMed ID: 37518950
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Chemistry of Alkaloids from Malaysian
Chear NJ; León F; Sharma A; Kanumuri SRR; Zwolinski G; Abboud KA; Singh D; Restrepo LF; Patel A; Hiranita T; Ramanathan S; Hampson AJ; McMahon LR; McCurdy CR
J Nat Prod; 2021 Apr; 84(4):1034-1043. PubMed ID: 33635670
[TBL] [Abstract][Full Text] [Related]
8. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
9. [Discrimination of Kratom Products by an Improved PCR-RFLP Method].
Ogata J; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R
Yakugaku Zasshi; 2020; 140(12):1501-1508. PubMed ID: 33268690
[TBL] [Abstract][Full Text] [Related]
10. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.
Zhang M; Sharma A; León F; Avery B; Kjelgren R; McCurdy CR; Pearson BJ
PLoS One; 2022; 17(4):e0259326. PubMed ID: 35472200
[TBL] [Abstract][Full Text] [Related]
11. A Chromosome-Scale Genome Assembly of
Pootakham W; Yoocha T; Jomchai N; Kongkachana W; Naktang C; Sonthirod C; Chowpongpang S; Aumpuchin P; Tangphatsornruang S
Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290398
[No Abstract] [Full Text] [Related]
12. Directed Biosynthesis of Mitragynine Stereoisomers.
Schotte C; Jiang Y; Grzech D; Dang TT; Laforest LC; León F; Mottinelli M; Nadakuduti SS; McCurdy CR; O'Connor SE
J Am Chem Soc; 2023 Mar; 145(9):4957-4963. PubMed ID: 36883326
[No Abstract] [Full Text] [Related]
13. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of ELISA for screening of Kratom (Mitragyna speciosa) habitual users using urinary AZ122 biomarker.
Jasim RK; Singh D; Gam LH
Biotechnol Appl Biochem; 2023 Apr; 70(2):707-715. PubMed ID: 35931067
[TBL] [Abstract][Full Text] [Related]
15. Kratom Alkaloids: A Blueprint?
Smith KE; Sharma A; Grundmann O; McCurdy CR
ACS Chem Neurosci; 2023 Jan; 14(2):195-197. PubMed ID: 36594896
[TBL] [Abstract][Full Text] [Related]
16. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
17. Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines.
Domnic G; Jeng-Yeou Chear N; Abdul Rahman SF; Ramanathan S; Lo KW; Singh D; Mohana-Kumaran N
J Ethnopharmacol; 2021 Oct; 279():114391. PubMed ID: 34224811
[TBL] [Abstract][Full Text] [Related]
18. Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves.
Veeramohan R; Zamani AI; Azizan KA; Goh HH; Aizat WM; Razak MFA; Yusof NSM; Mansor SM; Baharum SN; Ng CL
PLoS One; 2023; 18(3):e0283147. PubMed ID: 36943850
[TBL] [Abstract][Full Text] [Related]
19. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
[TBL] [Abstract][Full Text] [Related]
20. Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.
Grundmann O; Hill K; Al Barzanji E; Hazrat NG; Kaur G; Negeve RE; Shade S; Weber S; Veltri CA
J Ethnopharmacol; 2023 Dec; 317():116779. PubMed ID: 37364801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
